ArticleCancers2020

Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma.

Muhammad Yogi Pratama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.